FR2259594B1 - - Google Patents

Info

Publication number
FR2259594B1
FR2259594B1 FR7503404A FR7503404A FR2259594B1 FR 2259594 B1 FR2259594 B1 FR 2259594B1 FR 7503404 A FR7503404 A FR 7503404A FR 7503404 A FR7503404 A FR 7503404A FR 2259594 B1 FR2259594 B1 FR 2259594B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7503404A
Other versions
FR2259594A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2019974A external-priority patent/IT1059511B/it
Priority claimed from IT1926475A external-priority patent/IT1058295B/it
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Publication of FR2259594A1 publication Critical patent/FR2259594A1/fr
Application granted granted Critical
Publication of FR2259594B1 publication Critical patent/FR2259594B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
FR7503404A 1974-02-05 1975-02-04 Expired FR2259594B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2019974A IT1059511B (it) 1974-02-05 1974-02-05 Fenossialchilammine
IT1926475A IT1058295B (it) 1975-01-14 1975-01-14 Fenossialchilammine

Publications (2)

Publication Number Publication Date
FR2259594A1 FR2259594A1 (fr) 1975-08-29
FR2259594B1 true FR2259594B1 (fr) 1978-07-21

Family

ID=26327112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7503404A Expired FR2259594B1 (fr) 1974-02-05 1975-02-04

Country Status (8)

Country Link
US (1) US3988475A (fr)
JP (1) JPS5412458B2 (fr)
CA (1) CA1052791A (fr)
DE (1) DE2504790C3 (fr)
ES (1) ES434421A1 (fr)
FR (1) FR2259594B1 (fr)
GB (1) GB1500734A (fr)
NL (1) NL162062C (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493848A (en) * 1975-07-24 1977-11-30 Beecham Group Ltd Aryltetralins
US4155907A (en) * 1976-08-16 1979-05-22 The Dow Chemical Company Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines
DE3264523D1 (en) * 1981-04-06 1985-08-08 Cortial Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines
IT1240598B (it) * 1990-03-13 1993-12-17 Mini Ricerca Scient Tecnolog Derivati amminici ad azione antifungina
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
SE9704770D0 (sv) * 1997-12-19 1997-12-19 Astra Ab New use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
JPS4427369Y1 (fr) * 1966-12-01 1969-11-15
US3632779A (en) * 1969-03-06 1972-01-04 Dow Chemical Co Method using (dialkylaminoethoxy) halomethoxyanilines for alleviating cardiac arrhythmias

Also Published As

Publication number Publication date
NL7501371A (nl) 1975-08-07
US3988475A (en) 1976-10-26
JPS5412458B2 (fr) 1979-05-23
NL162062C (nl) 1980-04-15
CA1052791A (fr) 1979-04-17
GB1500734A (en) 1978-02-08
JPS50112326A (fr) 1975-09-03
AU7788875A (en) 1976-08-12
NL162062B (nl) 1979-11-15
ES434421A1 (es) 1977-03-16
DE2504790C3 (de) 1978-08-31
DE2504790A1 (de) 1975-08-07
FR2259594A1 (fr) 1975-08-29
DE2504790B2 (de) 1977-12-29

Similar Documents

Publication Publication Date Title
FR2261770B1 (fr)
JPS50126189A (fr)
FR2259594B1 (fr)
JPS50128500A (fr)
FR2329956B1 (fr)
JPS50108836U (fr)
FR2277822B1 (fr)
JPS50117605A (fr)
JPS50109971U (fr)
JPS50149704U (fr)
AR201233Q (fr)
JPS50118001U (fr)
JPS50118009A (fr)
JPS50131740U (fr)
JPS50147034A (fr)
AR198786Q (fr)
JPS50149829U (fr)
DK159874A (fr)
JPS50150572U (fr)
BE830261A (fr)
AU480578A (fr)
CH577643A5 (fr)
CH577779A5 (fr)
CH577574A5 (fr)
CH577406A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse